The Company is a Korea-based company mainly engaged in the manufacture and sale of medical devices. The Company s main products include wearable insulin pumps, insulin infusion regulators for blood sugar control in diabetic patients. The Company was established on September 27, 2011. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on September 14, 2020.
Headquarters
2102, H Dong, 172, Dolma-Ro, Bundang-Gu
Seongnam; Gyeonggi;
Contact Details: Purchase the Eoflowco.,Ltd report to view the information.
Website: http://www.eoflow.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service